MedTrace Logo

Cervical Cancer Detection Using Optical Spectroscopy

NCT00900575 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2026-03-06

No results posted yet for this study

Summary

The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.

Conditions

Interventions

DEVICE

Optical Spectroscopy Bench-Top System

This device is a bench-top optical spectrometer

DEVICE

Portable Optical Spectrometer

This device is a portable optical spectrometer

DEVICE

Transvaginal colposcope

Sponsors & Collaborators

Principal Investigators

  • Nimmi Ramanujam, Ph.D. · Duke University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2028-01-31
Completion
2028-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00900575 on ClinicalTrials.gov